Number | CD | Number | ND | P | |
---|---|---|---|---|---|
Sex (female) | 40 | 25 (63 %) | 49 | 34 (69 %) | 0.51 |
Age (year) | 40 | 55.8 ± 7.8 | 49 | 54.4 ± 8.3 | 0.43 |
BMI (kg m−2) | 40 | 31.9 ± 2.7 | 49 | 31.8 ± 3.1 | 0.90 |
Total cholesterol (mM) | 40 | 5.3 ± 1.0 | 49 | 5.3 ± 1.0 | 0.91 |
LDL cholesterol (mM) | 40 | 3.3 ± 0.9 | 49 | 3.2 ± 0.9 | 0.93 |
HDL cholesterol (mM) | 40 | 1.3 ± 0.5 | 49 | 1.4 ± 0.3 | 0.51 |
Fasting triglycerides (mM) | 40 | 1.5 ± 0.5 | 49 | 1.5 ± 0.7 | 0.84 |
Fasting glucose (mM) | 40 | 5.8 ± 0.6 | 49 | 5.8 ± 0.6 | 0.46 |
Fasting insulin (pM) | 40 | 59.5 (47.0–82.3) | 49 | 55.0 (41.0–75.5) | 0.43 |
IL1Ra (ng L−1) | 40 | 308.7 (233.4–465.6) | 49 | 203.8 (220.0–502.0) | 0.96 |
IL1β (ng L−1) | 39 | 0.12 (0.12–0.21) | 49 | 0.12 (0.12–0.14) | 0.44 |
IL6 (ng L−1) | 40 | 1.3 (1.1–1.8) | 49 | 1.3 (1.0–1.9) | 0.76 |
IL10 (ng L−1) | 39 | 0.9 (0.8–1.5) | 49 | 0.8 (0.8–1.5) | 0.32 |
sTNFRII (ng L−1) | 40 | 1899.6 ± 415.4 | 49 | 1954.5 ± 461.1 | 0.56 |
hs-CRP (mg L−1) | 40 | 1.5 (0.9–3.7) | 49 | 1.5 (0.8–2.9) | 0.68 |
HMW adiponectin (μg L−1) | 40 | 3.6 (2.2–6.7) | 49 | 4.0 (2.8–6.5) | 0.36 |
Lipid-lowering drugs | 40 | 13 (33 %) | 49 | 12 (25 %) | 0.48 |
Antihypertensive drugs | 40 | 20 (50 %) | 49 | 31 (63 %) | 0.28 |
Smoking | 40 | 6 (15 %) | 49 | 4 (8 %) | 0.34 |
Metabolic syndrome | 40 | 34 (85 %) | 49 | 42 (86 %) | 1.00 |